GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (NAS:STAA) » Definitions » Piotroski F-Score

Staar Surgical Co (Staar Surgical Co) Piotroski F-Score : 4 (As of May. 07, 2024)


View and export this data going back to 1983. Start your Free Trial

What is Staar Surgical Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Staar Surgical Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Staar Surgical Co's Piotroski F-Score or its related term are showing as below:

STAA' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Staar Surgical Co was 8. The lowest was 2. And the median was 6.


Staar Surgical Co Piotroski F-Score Historical Data

The historical data trend for Staar Surgical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Piotroski F-Score Chart

Staar Surgical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 4.00 7.00 7.00 4.00

Staar Surgical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 5.00 4.00 2.00 4.00

Competitive Comparison of Staar Surgical Co's Piotroski F-Score

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 2.71 + 6.064 + 4.817 + 7.756 = $21.3 Mil.
Cash Flow from Operations was -5.094 + -6.306 + -5.975 + 31.969 = $14.6 Mil.
Revenue was 73.528 + 92.306 + 80.308 + 76.273 = $322.4 Mil.
Gross Profit was 57.562 + 70.726 + 63.638 + 60.725 = $252.7 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(418.818 + 418.905 + 440.651 + 471.521 + 488.692) / 5 = $447.7174 Mil.
Total Assets at the begining of this year (Dec22) was $418.8 Mil.
Long-Term Debt & Capital Lease Obligation was $31.5 Mil.
Total Current Assets was $365.3 Mil.
Total Current Liabilities was $65.0 Mil.
Net Income was 9.602 + 13.038 + 10.262 + 6.763 = $39.7 Mil.

Revenue was 63.2 + 81.101 + 76.046 + 64.044 = $284.4 Mil.
Gross Profit was 49.264 + 63.872 + 60.462 + 49.785 = $223.4 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(345.778 + 351.177 + 376.025 + 394.676 + 418.818) / 5 = $377.2948 Mil.
Total Assets at the begining of last year (Dec21) was $345.8 Mil.
Long-Term Debt & Capital Lease Obligation was $27.3 Mil.
Total Current Assets was $311.7 Mil.
Total Current Liabilities was $51.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Staar Surgical Co's current Net Income (TTM) was 21.3. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Staar Surgical Co's current Cash Flow from Operations (TTM) was 14.6. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=21.347/418.818
=0.05096963

ROA (Last Year)=Net Income/Total Assets (Dec21)
=39.665/345.778
=0.11471233

Staar Surgical Co's return on assets of this year was 0.05096963. Staar Surgical Co's return on assets of last year was 0.11471233. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Staar Surgical Co's current Net Income (TTM) was 21.3. Staar Surgical Co's current Cash Flow from Operations (TTM) was 14.6. ==> 14.6 <= 21.3 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=31.467/447.7174
=0.07028317

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=27.346/377.2948
=0.07247913

Staar Surgical Co's gearing of this year was 0.07028317. Staar Surgical Co's gearing of last year was 0.07247913. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=365.269/65.036
=5.61641245

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=311.723/51.716
=6.02759301

Staar Surgical Co's current ratio of this year was 5.61641245. Staar Surgical Co's current ratio of last year was 6.02759301. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Staar Surgical Co's number of shares in issue this year was 49.226. Staar Surgical Co's number of shares in issue last year was 49.407. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=252.651/322.415
=0.78362049

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=223.383/284.391
=0.78547844

Staar Surgical Co's gross margin of this year was 0.78362049. Staar Surgical Co's gross margin of last year was 0.78547844. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=322.415/418.818
=0.76982126

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=284.391/345.778
=0.82246702

Staar Surgical Co's asset turnover of this year was 0.76982126. Staar Surgical Co's asset turnover of last year was 0.82246702. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+1+0+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Staar Surgical Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Staar Surgical Co  (NAS:STAA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Staar Surgical Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Staar Surgical Co (Staar Surgical Co) Business Description

Traded in Other Exchanges
Address
25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.
Executives
Broadwood Partners Lp 10 percent owner BROADWOOD CAPITAL INC., 142 WEST 57TH STREET, 11TH FLOOR, NEW YORK NY 10019
Elizabeth Yeu Lin director 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
Aimee S Weisner director ONE EDWARDS WAY, IRVINE CA 92614
Warren Foust officer: Chief Operating Officer 17 MAGNOLIA DRIVE, LADERA RANCH CA 92694
Magda Michna officer: Chief Clinical, Regulatory, C/O PRESBIA, 8845 IRVINE CENTER DRIVE, SUITE 100, IRVINE CA 92618
Keith Holliday officer: V.P., Research & Development 1911 WALKER AVENUE, MONROVIA CA 91016
Robert Studholme officer: Senior VP, Operations 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
James E Francese officer: VP, Global Marketing 1911 WALKER AVE, MONROVIA CA 91016
Caren L Mason director 2523 PARK RIDGE DRIVE, ESCONDIDO CA 92025
Samuel J Gesten officer: VP, General Counsel 1911 WALKER AVENUE, MONROVIA CA 91016
Patrick F. Williams officer: Chief Financial Officer C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Hans-martin Blickensdoerfer officer: VP, International Marketing 1911 WALKER AVENUE, MONROVIA CA 91016
Lou Silverman director
Graydon C. Hansen officer: Sr. VP, Global Operations 25651 ATLANTIC OCEAN DRIVE, LAKE FORST CA 92630
Jon K. Hayashida officer: VP, Global Clinical, Medical 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630